Medical College of Wisconsin: Neoplasms trials

The registry lists 11 Neoplasms studies with Medical College of Wisconsin as lead sponsor. 6 are open to participants now and 1 have results posted.

Phase 1 4Phase 2 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeNot yet recruitingNCT07754292Phase 2
• Determining Individualized Cancer Therapy in Pancreatic CancerRecruitingNCT05914987
• Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor PrognosesRecruitingNCT05674825Phase 1/2
• Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic MalignanciesRecruitingNCT05544968Phase 1
• PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility StudyNot yet recruitingNCT05377320
• Intra- and Inter-fraction Changes in Radiation TherapyRecruitingNCT02344121
• Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck CancerCompletedNCT04477759Phase 1Results posted
• Solid Tumor Imaging MR-Linac (STIM Study)SuspendedNCT03500081
• Pretransplant Evaluation by Supportive Care Team for Patients Undergoing HCT for Hematological MalignanciesCompletedNCT02321345Not applicable
• Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationStatus unknownNCT00036712Phase 2
• Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid TumorsCompletedNCT00002543Phase 1